NCT06409806 Electrocorticographic Monitoring of Brain Retraction Injury (EMBRI)
| NCT ID | NCT06409806 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University College, London |
| Condition | Brain Injury |
| Study Type | INTERVENTIONAL |
| Enrollment | 6 participants |
| Start Date | 2022-08-01 |
| Primary Completion | 2024-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 6 participants in total. It began in 2022-08-01 with a primary completion date of 2024-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A single centre IDEAL Stage 1 feasibility study using novel electrophysiological recording techniques in adult participants undergoing neurosurgery. This is a first in human study, building upon previous preclinical mice experiments. Participants will undergo their planned neurosurgical procedure as normal. In addition to their standard treatment neurophysiological monitoring including an electrocorticography electrode placed on the brain deep to the retractor will be used to monitor for signs of brain retraction injury.
Eligibility Criteria
Inclusion Criteria: * Patients aged 16 or older undergoing intracranial surgery where it is anticipated fixed brain retraction will be used. Exclusion Criteria: * Patients without capacity to give consent at time of recruitment
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06409806 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, studying Brain Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06409806 currently recruiting?
Yes, NCT06409806 is actively recruiting participants. Contact the research team at siddharth.sinha@ucl.ac.uk for enrollment information.
Where is the NCT06409806 trial being conducted?
This trial is being conducted at London, United Kingdom.
Who is sponsoring the NCT06409806 clinical trial?
NCT06409806 is sponsored by University College, London. The trial plans to enroll 6 participants.